Billiontoone (NASDAQ:BLLN) Shares Gap Down Following Insider Selling

Billiontoone, Inc. (NASDAQ:BLLN) gapped down prior to trading on Thursday following insider selling activity. The stock had previously closed at $113.89, but opened at $101.40. Billiontoone shares last traded at $107.2220, with a volume of 305,885 shares changing hands.

Specifically, CTO David Tsao sold 20,000 shares of the stock in a transaction that occurred on Monday, November 2nd. The shares were sold at an average price of $109.24, for a total transaction of $2,184,800.00. Following the sale, the chief technology officer owned 1,000 shares in the company, valued at approximately $109,240. This trade represents a 95.24% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Oguzhan Atay sold 5,334 shares of the business’s stock in a transaction that occurred on Monday, November 2nd. The shares were sold at an average price of $113.17, for a total transaction of $603,648.78. Following the transaction, the chief executive officer owned 141,167 shares of the company’s stock, valued at approximately $15,975,869.39. This represents a 3.64% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In other news, CEO Oguzhan Atay sold 25,001 shares of the business’s stock in a transaction on Monday, November 2nd. The stock was sold at an average price of $109.24, for a total transaction of $2,731,109.24. Following the completion of the transaction, the chief executive officer owned 16,667 shares of the company’s stock, valued at approximately $1,820,703.08. The trade was a 60.00% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. Zacks Research raised Billiontoone from a “strong sell” rating to a “hold” rating in a research note on Friday, October 2nd. Canaccord Genuity Group initiated coverage on Billiontoone in a research note on Wednesday, September 2nd. They set a “buy” rating and a $120.00 target price for the company. JPMorgan Chase & Co. dropped their target price on shares of Billiontoone from $145.00 to $130.00 and set an “overweight” rating for the company in a report on Thursday, August 6th. Guggenheim upped their price objective on shares of Billiontoone from $125.00 to $128.00 and gave the stock a “buy” rating in a research report on Thursday, October 1st. Finally, Wall Street Zen lowered shares of Billiontoone from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Seven research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $126.25.

More Billiontoone News

Here are the key news stories impacting Billiontoone this week:

• Positive Sentiment: Q3 beat estimates: Revenue was approximately $123.0 million, above the $115.8 million FactSet estimate. Earnings also topped the $0.16-per-share consensus, though reports cite differing actual EPS figures. BillionToOne Q3 results and guidance
• Positive Sentiment: 2026 outlook raised: BillionToOne increased its full-year revenue forecast to $460 million–$470 million, signaling stronger expected growth. Revenue outlook and Northstar Clear news
• Positive Sentiment: New product planned: The company said it plans to launch Northstar Clear on December 15, offering a potential additional growth catalyst. Northstar Clear launch news
• Positive Sentiment: Buy rating reaffirmed: BTIG Research maintained its “buy” rating and a $130 price target, about 14% above the cited $113.89 share price. BTIG Research recommendations
• Negative Sentiment: Executives reported stock sales: The CEO, CTO and an SVP sold shares. The transactions were made under pre-arranged Rule 10b5-1 plans, which may lessen—but do not remove—investor concern about insider selling. BillionToOne insider transaction report

Billiontoone Price Performance

The company has a 50 day moving average price of $104.67 and a 200-day moving average price of $96.89. The company has a market cap of $5.10 billion and a price-to-earnings ratio of 155.77. The company has a quick ratio of 11.31, a current ratio of 11.69 and a debt-to-equity ratio of 0.17.

Billiontoone (NASDAQ:BLLN) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.15. The firm had revenue of $109.45 million during the quarter. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. As a group, equities research analysts predict that Billiontoone, Inc. will post 0.80 EPS for the current fiscal year.

Institutional Trading of Billiontoone

A number of large investors have recently bought and sold shares of BLLN. Penn Capital Management Company LLC increased its holdings in Billiontoone by 2.3% in the third quarter. Penn Capital Management Company LLC now owns 132,636 shares of the company’s stock worth $14,143,000 after purchasing an additional 3,034 shares in the last quarter. Parallel Advisors LLC grew its position in shares of Billiontoone by 86.7% during the 3rd quarter. Parallel Advisors LLC now owns 280 shares of the company’s stock worth $30,000 after buying an additional 130 shares during the period. Provenance Wealth Advisors LLC acquired a new stake in shares of Billiontoone during the 3rd quarter worth approximately $56,000. D.A. Davidson & CO. bought a new stake in shares of Billiontoone in the 3rd quarter valued at $773,000. Finally, Forum Financial Management LP bought a new stake in shares of Billiontoone in the 3rd quarter valued at $274,000.

Billiontoone Company Profile

BillionToOne, Inc is a molecular diagnostics company that develops tests designed to provide more sensitive and quantitative genetic information from blood samples. The company’s technology is based on its proprietary Quantitative Counting Template (QCT) platform, which is designed to measure DNA molecules with high sensitivity and support the detection of clinically meaningful genetic signals.

The company’s products include prenatal diagnostic and screening solutions marketed under the UNITY brand.